p300-mediated acetylation of KCNN4 drives enzalutamide resistance in prostate cancer

Weiqiang Song1, Jiankun Zhang1, Zekun Xin1

  • 1Department of Urology, Hebei Petrochina Central Hospital, Xinkai Road NO.51, Langfang City, Hebei Province, 065000, China.

Experimental Cell Research
|February 14, 2026
PubMed

Insights

Targeting the p300-KCNN4 pathway can overcome enzalutamide resistance in prostate cancer. Inhibiting p300 stabilizes KCNN4, resensitizing resistant cells to treatment and suppressing tumor growth.

Area of Science:

  • Oncology
  • Molecular Biology
  • Epigenetics

Background:

  • Enzalutamide resistance is a major challenge in castration-resistant prostate cancer (CRPC).
  • Potassium calcium-activated channel subfamily N member 4 (KCNN4) is implicated in therapeutic failure.
  • Understanding resistance mechanisms is crucial for developing effective treatments.

Purpose of the Study:

  • To investigate the role of KCNN4 in enzalutamide resistance.
  • To elucidate the regulatory mechanism of KCNN4 stability.
  • To explore therapeutic strategies targeting the p300-KCNN4 axis.

Main Methods:

  • Analysis of KCNN4 expression in enzalutamide-resistant prostate cancer (PCa) cells and clinical tissues.
  • Investigation of the interaction between p300 and KCNN4 using biochemical assays.
  • Assessment of the effects of p300 inhibition on KCNN4 acetylation, degradation, and enzalutamide sensitivity in vitro and in vivo.
  • Evaluation of KCNN4 knockdown in combination with enzalutamide in xenograft models.

Main Results:

  • KCNN4 is upregulated in resistant PCa, correlating with poor prognosis.
  • p300 acetylates KCNN4 at lysine 16, inhibiting its ubiquitination and degradation, thus stabilizing the protein.
  • p300 inhibition reduces KCNN4 acetylation, promotes its degradation, and resensitizes resistant cells to enzalutamide.
  • KCNN4 knockdown suppresses tumor growth and synergizes with enzalutamide.

Conclusions:

  • A novel epigenetic mechanism links p300-mediated acetylation to KCNN4 stability.
  • Targeting the p300-KCNN4 axis offers a promising strategy to overcome enzalutamide resistance in advanced prostate cancer.
  • This approach could improve therapeutic outcomes for CRPC patients.

Related Concept Videos

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.8K
Phase II Reactions: Acetylation Reactions01:24

Phase II Reactions: Acetylation Reactions

Acetylation, a phase II biotransformation reaction, introduces an acetyl group to drugs or their metabolites. Acetyltransferase enzymes facilitate this reaction, which resembles α-amino acid conjugation due to the addition of a functional group to the drug molecule.
The substrates for acetylation are typically drugs or their metabolites with an amino, sulfonamide, or hydrazine functional group. Acetylation can occur at several points in the drug molecule, including primary, secondary, and...
864
Energy to Drive Translocation01:37

Energy to Drive Translocation

Mitochondrial protein import is powered by two distinct energy sources: ATP hydrolysis and electrochemical potential across the inner membrane. Newly synthesized precursors are bound by cytosolic chaperones of the Hsp70 family, which guide them to the import receptors on the mitochondrial surface. Utilizing the energy of ATP hydrolysis, Hsp70 chaperones transfer these precursors to the TOM receptors on the mitochondrial outer membrane.
Generally, polypeptides are unfolded by two distinct...
2.9K
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
6.6K
Resistivity01:22

Resistivity

When a voltage is applied to a conductor, an electrical field is generated, and charges in the conductor feel the force due to the electrical field. The current density that results depends on the electrical field and the properties of the material. In some materials, including metals at a given temperature, the current density is approximately proportional to the electrical field. In these cases, the current density can be modeled as:
4.6K
Resistance01:19

Resistance

When a current moves through any conductor, the conductor causes some level of difficulty for the current to flow. The measure of that difficulty is known as the resistance of the material and is represented by R. Every material has its own resistance. In the case of conductors, heat is emitted whenever a current passes through them. Resistance depends on the resistivity of the material. Resistivity is a characteristic of the material used to fabricate electrical components, whereas the...
6.1K